CORCEPT THERAPEUTICS INC — Director's Dealing 2010

Apr 23, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2010-04-21

Reporting Person: SHEEHAN ANDREW T (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-04-21	Common Stock	X	1059	$1.66	Acquired	19384	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-04-21	Common Stock Warrant	$1.66	X	1059	Disposed	2012-10-16	Common Stock (1059)	Indirect
2010-04-21	Common Stock Warrant	$2.96	P	1059	Acquired	2013-04-21	Common Stock (1059)	Indirect

Footnotes

F1: Issuance of common stock upon exercise of warrants in accordance with the Securities Purchase Agreement dated as of October 12, 2009.

F2: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust.

F3: Purchase price per unit. Each unit consists of 1 common share and a warrant to purchase 0.35 of a share of common stock at an exercise price of $1.66 per share.

F4: Acquired from the issuer pursuant to a Warrant Purchase Agreement dated April 21, 2010 whereby purchase of the new warrants was conditioned upon the exercise of warrants that had been issued in October 2009 (see also Footnote #1 above).